Skip to main navigation

Upstream Bio, Targeting Inflammation at Its Source for Better Health

About
- Leadership
- Board
Science
- TSLP
- Publications
Pipeline
- Verekitug
Patients
- Clinical Trials
- Disease Focus
Join Us
Investors

About

Science

Pipeline

Patients

Join Us

Investor

News

Back

Team

Leadership
Board
Advisors
Investors

Back

News

Press Releases
In The News

Back

Investor

Overview
News & Events
Stock
- Stock Quote & Chart
Corporate Governance
- Documents & Charters
- Committee Composition
Financial Information
- SEC Filings
Shareholder Services

Event Details

Stifel 2025 Virtual Immunology and Inflammation Forum

September 15, 2025 10:30 AM EDT

Click here for webcast

Upstream Bio, Targeting Inflammation at Its Source for Better Health

LinkedIn
Twitter

info@upstreambio.com
890 Winter Street
Suite 200
Waltham, MA 02451

About
- Board of Directors
- Leadership
Science
- TSLP
- Publications

Pipeline
- Verekitug
Patients
- Clinical Trials
- Disease Info

Join Us
Investors

© 2026 Upstream Bio | Privacy Policy | Terms of Use
EEA Investigators and Site Personnel Notice | Privacy Notice for Clinical Study Participants | Data Privacy Framework Privacy Notice